GFER/ALR Antibody [DyLight 594]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-97019DL594
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA, Immunohistochemistry-Paraffin
Label
DyLight 594 (Excitation = 593 nm, Emission = 618 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for GFER/ALR Antibody [DyLight 594]
Immunogen
Produced in rabbits immunized with purified, recombinant Human GFER/ALR (Accession#: NP_005253.3; Met1-Asp125)
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for GFER/ALR Antibody [DyLight 594]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen and protein A Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: GFER/ALR
Long Name
Growth Factor, Augmenter of Liver Regeneration
Alternate Names
ALR, ERV1, Hepatopoietin, HERV1, HPO
Gene Symbol
GFER
Additional GFER/ALR Products
Product Documents for GFER/ALR Antibody [DyLight 594]
Product Specific Notices for GFER/ALR Antibody [DyLight 594]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...